Animal | Location of coenuri | Infection (dose) | No. treated animals | Start treatment | Medication (route of administration) | Dose mg/kg (period) | Efficacy % | Efficacy testing, time after treatment | Remarks | Reference |
---|---|---|---|---|---|---|---|---|---|---|
Lambs 5 months old | Cerebral | Exp (2400 eggs) | 2 | 36 days | MBZ (IP) | 40 (S) | 0.0 | Degenerative changes in coenuri, 78 days PT | MBZ is ineffective to treat cerebral coenurosis | [14] |
3 | MBZ | 100 (14 days) | 0.0 | |||||||
Lambs 4–5 months old | Cerebral | Exp (6500 eggs) | 5 | CL | ALB | 25 (6 days) | 100 | Degenerate/dead coenuri, after recovery | 2/5 and 1/5 of FEN and PRZ-treated groups died before necropsy. Likewise, 5/5 of control group died before necropsy. Caseated and calcified cysts were noticed in the treated groups, but most commonly in those treated with ALB or FEN-PRZ comb. Authors claimed albendazole was the most effective | [17] |
5 | FEN | 25 (8 days) | 71.4 | |||||||
5 | PRZ | 100 (7 days) | 85.3 | |||||||
5 | FEN-PRZ Comb | **** | 100 | |||||||
5 | Control | – | 0.0 | |||||||
Lambs 3–4 months old | Cerebral | Exp (5500 eggs) | 7 | CL | PRZ | 25 (3 days) | 100 | Degenerated/dead coenuri, after recovery | 5/7 lambs from PRZ group and 4 of ALB group died before necropsy. Dogs fed protoscolices from treated groups were not infected | [20] |
7 | ALB | 10 (14 days) | 54.8 | |||||||
7 | Control | – | 2.8 | |||||||
Sheep | Cerebral | Nat | 2 | CL | PRZ | 7.5 (6 days) | NS | Clearance of neurological symptoms | One PRZ-treated animal survived, and general conditions of the remaining animals worsened. No improvement occurred in OXF-treated sheep | [24] |
6 | PRZ | 50 (2 days) | NS | |||||||
2 | OXF | 30 (S) | 0.0 | |||||||
Sheep | Cerebral | Nat | NS | – | PRZ | 100 | NS | Degenerated cysts, transmission to dogs | Calcified coenuri in brains of treated sheep. Coenuri in untreated sheep were alive. Dogs fed on brains of treated sheep did not have tapeworms | [26] |
Sheep | Cerebral | Exp (50,000 eggs) | 1 | 15 days | PRZ | 100 (5 days) | Â | 21-day PT | Clinical signs of acute coenurosis appeared 17-day PI. No improvement occurred when treated. Numerous migratory tracts were evidenced in the brain. No live coenuri were detected | [28] |
Exp (n = 11; 5000 eggs), Nat (n = 2) | 2 | 2–11 months | PRZ | 100 (5 days) | 0.0 | Recovery (clearance of neurological symptoms), dead coenuri, transmission to dogs, 1–> 3 months PT | Clinical symptoms disappeared. No coenuri were recovered from the brains | |||
2 | PRZ | 100 (2 days) | 100 | |||||||
4 | PRZ | 100 (S) | 100 | |||||||
1 | PRZ | 50 (5) | 100 | |||||||
4 | PRZ | 50 (S) | 50.0 | Variable response to treatment. Clinical improvement occurred in 2 sheep and dead coenuri were detected in their brains. One sheep responded but the clinical symptoms reappeared 3 months later One sheep did not respond and mature coenuri were detected in the brain | ||||||
Sheep | Cerebral | Exp (5500 eggs) | 2 | CL | PRZ | 100 (5 days) | 100 | Non-viable/degenerated coenuri, 30-day PT | All treatments were effective. Dogs that fed on the coenuri collected after killing the included sheep, did not develop adult worms. PRZ is highly effective | [29] |
2 | 100 (2 days) | |||||||||
1 | 50 (5 days) | |||||||||
Goats | Non-cerebral | Exp (3000 eggs) | 7 | 2 months PI | ALB | 10 (3 days) | 90.3 | Non-viable/viable coenuri, 10 days PT | Significant variation in occurrence of non-viable coenuri when goats received albendazole 2 months post infection | [32] |
6 | 2 months PI | ALB | 10 (S) | 72.7 | ||||||
6 | 2 months PI | ALB | 20 (S) | 73.9 | ||||||
12 | 2 months PI | Control | – | 13.6 | ||||||
5 | 5 months PI | ALB | 10 (3) | 88.6 | ||||||
5 | 5 months PI | Control | – | 84.6 | ||||||
Goats | Non-cerebral | Nat | 12 | – | FEN | 7.5 | NS | – | FEN is effective in treating non-cerebral coenuri in goats | [33] |
Sheep | Cerebral | Nat | 20 | – | FEN-PRZ Comb | 10 + 3 (5 days) | 84.0 | Recovery (clearance of neurological symptoms) | Neurologically-diseased. No confirmed diagnosis, based on the history and clinical signs | [48] |
Sheep | Cerebral | Nat | NS | – | PRZ | 50–100 (3 days) | NS | Occurrence of neurological symptoms | Apparently healthy sheep from flocks with endemic coenurosis. No cases have been reported for 6 months PT | [49] |
Sheep | Cerebral | Nat | 61 | – | PRZ | 80–100 | NS | Recovery (clearance of neurological symptoms) | 56 sheep received treatment. Recovery occurred in 43 (70.5%), and 13 died. Intramuscular administration gave better results than the oral route | [50] |
PRZ (IM) | 40–50 | NS | ||||||||
Lambs | Cerebral | Nat | 3 | CL | ALB | 25 (2 doses 2 weeks apart) | 0.0 | Clearance of neurological symptoms | The treated lambs (n = 3) died despite this treatment. No new cases of the disease were observed after the initiation of control measures | [51] |
Lambs | Cerebral | Exp | 5 | NS | FEN | 0.75 –1 g | NS | Occurrence of neurological symptoms | No clinical signs appeared in any treated animal. Acute signs of the disease occurred in the controls. No coenuri were detected in brains of the treated lambs. FEN was administered prophylactically to lambs in a flock with a history of coenurosis, and symptoms of the disease did not recur | [52] |
5 | PRZ | 25 (6 doses 20-day interval) | Â |